Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Ophthalmology therapeutics Market Research Reports

Titlepublishedprice

Keratitis - Pipeline Review, H2 2015

By Global Markets Direct
"...... cs assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Keratit......"
25-Nov-2015$2000

Bacterial Conjunctivitis - Pipeline Review, H2 2015

By Global Markets Direct
"...... rative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involv......"
25-Nov-2015$2000

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2015

By Global Markets Direct
"...... CA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also re......"
25-Nov-2015$2000

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Assessment to 2024

By GlobalData
"...... d few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and Mucosta in 2010 and 2013, respectively. However, the lack of treatment options is about to change with the expected launch of nume......"
05-Nov-2015$10995

Dry Eye Syndrome - Current and Future Players

By GlobalData
"...... is on the companies in the rapidly growing Dry Eye Syndrome Market. The report identifies and analyses the key companies shaping and driving the global Dry Eye Syndrome market. The report provides insight into the competitive Dry Eye Syndrome landsca......"
05-Nov-2015$2995

Dry Eye Syndrome - US Drug Forecast and Market Analysis to 2024

By GlobalData
"...... iscomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and M......"
05-Nov-2015$4995

Dry Eye Syndrome - Japan Drug Forecast and Market Analysis to 2024

By GlobalData
"...... iscomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and M......"
05-Nov-2015$4995

Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2024

By GlobalData
"...... iscomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and M......"
05-Nov-2015$4995

Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2024

By GlobalData
"...... iscomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and M......"
05-Nov-2015$4995

Dry Eye Syndrome - 5EU Drug Forecast and Market Analysis to 2024

By GlobalData
"...... iscomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and M......"
05-Nov-2015$6995

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy